{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T02:53:33Z","timestamp":1726109613078},"edition-number":"0","reference-count":1,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429271663"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,13]]},"DOI":"10.3109\/9780203639115-42","type":"book-chapter","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T22:55:08Z","timestamp":1614984908000},"page":"609-620","source":"Crossref","is-referenced-by-count":0,"title":["Combination therapies in multiple sclerosis"],"prefix":"10.3109","member":"301","reference":[{"key":"ref31","doi-asserted-by":"crossref","unstructured":"1 The IFN\u03b2 Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebocontrolled trial. Neurology 1993; 43:655\u2013661.","DOI":"10.1212\/WNL.43.4.655"}],"container-title":["Multiple Sclerosis Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T22:56:20Z","timestamp":1614984980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9780203639115\/chapters\/10.3109\/9780203639115-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"ISBN":["9780429271663"],"references-count":1,"URL":"https:\/\/doi.org\/10.3109\/9780203639115-42","relation":{},"subject":[],"published":{"date-parts":[[2019,2,13]]}}}